To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C2orf24TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
415 supporting clones for gene C2orf24 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI546140 brain, hippocampus .a 1 to 765 1 to 769   tiling clone,   769/795
(96 %)
17 diff
(97.9 %id)
TI_44166234   .a 6 to 765 91 to 854       764/880
(86 %)
18 diff
(98.0 %id)
BM805473 brain, hippocampus .a 65 to 993 27 to 960       934/1114
(83 %)
27 diff
(97.6 %id)
BI918427 brain .a 80 to 852 1 to 777       777/782
(99 %)
7 diff
(99.2 %id)
TI_57238279   .a 80 to 852 1 to 777       777/782
(99 %)
7 diff
(99.2 %id)
BI912613 brain .a 114 to 880 1 to 766       766/902
(84 %)
6 diff
(99.4 %id)
TI_57238401   .a 114 to 1008 38 to 935       898/939
(95 %)
27 diff
(97.2 %id)
BM547667 brain, hippocampus .a 124 to 985 1 to 871       871/1055
(82 %)
22 diff
(98.0 %id)
DB489464 hypothalamus .a 125 to 601 1 to 470       472/470
(100 %)
13 diff
(97.3 %id)
BI488697 brain .a 134 to 1053 1 to 926       925/951
(97 %)
48 diff
(95.0 %id)
TI_45379382   .a 134 to 1053 100 to 1025       925/1050
(88 %)
54 diff
(94.9 %id)
BP360253 thalamus .a 155 to 733 1 to 581       581/582
(99 %)
5 diff
(99.2 %id)
BI759799 pooled colon, kidney, stomach .a 161 to 974 1 to 813       813/813
(100 %)
4 diff
(99.6 %id)
CD627205   .a 175 to 922 1 to 753       753/753
(100 %)
14 diff
(98.2 %id)
BQ890561 melanotic melanoma, cell line, skin .a 181 to 1027 1 to 857   tiling clone,   857/934
(91 %)
13 diff
(98.7 %id)
CR457401   .a 188 to 1419 1 to 1232   tiling clone,   1232/1233
(99 %)
7 diff
(99.5 %id)
TI_1948077627   .a 188 to 1063 129 to 1004       876/1214
(72 %)
14 diff
(98.9 %id)
TI_1948078268   .a 188 to 1062 131 to 1009       879/1182
(74 %)
33 diff
(97.3 %id)
TI_1948078269   .a 188 to 1209 132 to 1158       1027/1199
(85 %)
30 diff
(97.5 %id)
CA440442 Chondrosarcoma, Left Pubic Bone .a 940 to 1493 571 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 553/553
(100 %)
2 diff
(99.7 %id)
DB444453 testis .b 1 to 413 1 to 413   tiling clone,   413/413
(100 %)
2 diff
(99.6 %id)
AL526793 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 6 to 952 1 to 949       949/949
(100 %)
43 diff
(95.5 %id)
TI_45236336   .b 21 to 634 68 to 690       621/1303
(47 %)
21 diff
(98.4 %id)
BI766723 pooled lung and spleen .b 37 to 841 1 to 808       808/808
(100 %)
11 diff
(98.7 %id)
AL545683 placenta, Placenta Cot 25-normalized .b 39 to 761 2 to 723       722/1143
(63 %)
9 diff
(99.3 %id)
AL559464 T cells from T cell leukemia .b 39 to 845 2 to 808       805/808
(99 %)
3 diff
(99.7 %id)
TI_57148483   .b 44 to 855 17 to 840       837/840
(99 %)
59 diff
(93.0 %id)
TI_57180778   .b 44 to 841 25 to 836       823/836
(98 %)
66 diff
(92.2 %id)
R56594 whole brain .b 47 to 448 1 to 404       404/441
(91 %)
9 diff
(98.0 %id)
CR621433 Neuroblastoma Cot 25-normalized .b 55 to 1939 1 to 1885   tiling clone,   1885/1885
(100 %)
0 diff
(100 %id)
AL524075 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 55 to 996 1 to 933   fully sequenced,   933/933
(100 %)
9 diff
(99.1 %id)
BE292950 adenocarcinoma cell line, colon .b 60 to 697 1 to 640       640/640
(100 %)
9 diff
(98.6 %id)
BQ892658 melanotic melanoma, cell line, skin .b 62 to 734 1 to 677       677/907
(74 %)
16 diff
(98.3 %id)
CN306159 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 67 to 645 1 to 579       579/582
(99 %)
4 diff
(99.4 %id)
CV027686 mixed .b 69 to 697 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
CV028824 mixed .b 69 to 590 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
TI_1948077626   .b 69 to 761 126 to 817       692/1130
(61 %)
18 diff
(98.5 %id)
TI_1948077947   .b 69 to 761 127 to 820       694/1167
(59 %)
30 diff
(97.5 %id)
TI_1948078598   .b 69 to 758 124 to 813       690/1136
(60 %)
32 diff
(97.2 %id)
TI_1948094028   .b 69 to 645 145 to 723       579/1261
(45 %)
24 diff
(98.1 %id)
BQ335361 marrow .b 74 to 424 1 to 352       352/352
(100 %)
8 diff
(97.8 %id)
BU153663 eye, retinoblastoma .b 165 to 993 1 to 833       833/895
(93 %)
16 diff
(98.3 %id)
BM810611 astrocytoma grade IV, cell line, brain .b 167 to 1012 13 to 859       847/1096
(77 %)
35 diff
(96.9 %id)
BG478623 melanotic melanoma, skin .b 170 to 935 1 to 768       768/893
(86 %)
25 diff
(97.3 %id)
BG758960 B-cells, primary B-cells from tonsils (cell line) .b 180 to 1045 1 to 867       867/869
(99 %)
28 diff
(96.8 %id)
BG822972 adenocarcinoma cell line, colon .b 201 to 1009 1 to 820       820/834
(98 %)
30 diff
(96.5 %id)
BG824794 adenocarcinoma cell line, colon .b 201 to 986 1 to 792       792/834
(94 %)
27 diff
(96.8 %id)
TI_1948078270   .b 231 to 1300 1197 to 130       1068/1284
(83 %)
31 diff
(97.6 %id)
AA306208   .b 232 to 596 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
BE560173 Burkitt lymphoma, lymph .b 249 to 801 1 to 552       552/552
(100 %)
3 diff
(99.5 %id)
BG387553 embryonal carcinoma, cell line, testis .b 260 to 928 1 to 671       671/1092
(61 %)
15 diff
(98.7 %id)
BG681630 skin, squamous cell carcinoma .b 264 to 1025 1 to 794       689/794
(86 %)
41 diff
(94.9 %id)
EL946831 eyeball .b 275 to 663 1 to 395       393/395
(99 %)
11 diff
(97.3 %id)
CD627204   .b 279 to 865 595 to 14       582/595
(97 %)
11 diff
(98.2 %id)
BF346878 anaplastic oligodendroglioma with 1p/19qloss, brain .b 312 to 1025 25 to 738       714/756
(94 %)
12 diff
(98.5 %id)
TI_1948077628   .b 329 to 1300 1096 to 127       970/1270
(76 %)
15 diff
(98.9 %id)
BQ421715 melanotic melanoma, skin .b 333 to 1048 11 to 740       730/921
(79 %)
37 diff
(96.0 %id)
CN306158 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 356 to 979 8 to 632       625/638
(97 %)
8 diff
(98.8 %id)
BF934825 nervous_tumor .b 396 to 717 1 to 322       322/323
(99 %)
6 diff
(98.2 %id)
BE745683 adenocarcinoma cell line, ovary .b 405 to 1195 1 to 783       783/891
(87 %)
35 diff
(96.1 %id)
BF818775 colon_ins .b 406 to 815 1 to 412       412/419
(98 %)
8 diff
(98.1 %id)
BI023151 marrow .b 407 to 789 33 to 415       383/415
(92 %)
8 diff
(98.1 %id)
BF346804 anaplastic oligodendroglioma with 1p/19qloss, brain .b 407 to 1044 12 to 645       634/646
(98 %)
19 diff
(97.1 %id)
BQ642747 lymph, lymphoma, cell line .b 427 to 1337 1 to 920       824/922
(89 %)
13 diff
(98.6 %id)
BG681893 skin, squamous cell carcinoma .b 440 to 1042 1 to 606       606/767
(79 %)
15 diff
(98.1 %id)
EL955337 eyeball .b 441 to 758 8 to 324       317/324
(97 %)
2 diff
(99.4 %id)
TI_1948077949   .b 444 to 1300 971 to 120       852/1317
(64 %)
58 diff
(95.6 %id)
CA454635   .b 445 to 1320 1 to 881       881/902
(97 %)
12 diff
(98.7 %id)
TI_1948077629   .b 447 to 1300 976 to 129       848/1260
(67 %)
33 diff
(97.4 %id)
TI_1948078600   .b 452 to 1300 973 to 126       848/1300
(65 %)
6 diff
(99.6 %id)
TI_1948078271   .b 463 to 1300 961 to 132       830/1234
(67 %)
25 diff
(98.0 %id)
BE747720 adenocarcinoma cell line, ovary .b 479 to 1048 1 to 582       582/781
(74 %)
21 diff
(97.4 %id)
AA378810 synovial membrane .b 481 to 772 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
AL533465 adult brain, brain .b 484 to 1038 1 to 549       549/918
(59 %)
22 diff
(97.7 %id)
CR600598 adult brain .b 485 to 1501 1 to 1017       1017/1017
(100 %)
0 diff
(100 %id)
TI_1948077950   .b 485 to 1300 935 to 128       810/1240
(65 %)
16 diff
(98.8 %id)
BG819006 anaplastic oligodendroglioma with 1p/19qloss, brain .b 488 to 1133 1 to 647       647/824
(78 %)
19 diff
(97.7 %id)
CX871797 embryonic stem .b 493 to 1147 1 to 654       654/654
(100 %)
4 diff
(99.4 %id)
BF932205 nervous_tumor .b 522 to 914 398 to 5     Submitted on the opposite strand 394/398
(98 %)
6 diff
(98.5 %id)
BU185032 melanotic melanoma, cell line, skin .b 525 to 1314 1 to 800       800/894
(89 %)
43 diff
(95.2 %id)
BQ680834 melanotic melanoma, cell line, skin .b 525 to 844 1 to 320       320/970
(32 %)
5 diff
(99.5 %id)
BQ682100 melanotic melanoma, cell line, skin .b 525 to 1255 1 to 731       731/944
(77 %)
19 diff
(98.0 %id)
BU174399 melanotic melanoma, cell line, skin .b 525 to 1218 1 to 706       706/864
(81 %)
24 diff
(97.3 %id)
BQ678355 melanotic melanoma, cell line, skin .b 525 to 1425 1 to 911       911/918
(99 %)
31 diff
(96.7 %id)
TI_57229878   .b 528 to 1415 88 to 982       895/898
(99 %)
30 diff
(96.7 %id)
BI870929 adenocarcinoma, cell line, Liver .b 529 to 1415 1 to 894       894/897
(99 %)
30 diff
(96.7 %id)
AA306054   .b 554 to 860 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
BY997360   .b 576 to 1267 3 to 694       692/694
(99 %)
7 diff
(99.0 %id)
TI_1948078601   .b 577 to 1300 846 to 128       719/1221
(58 %)
7 diff
(99.5 %id)
BQ345095 nervous_tumor .b 595 to 693 1 to 99       99/99
(100 %)
8 diff
(92.0 %id)
CU456899 epidermis .b 595 to 891 313 to 17     Submitted on the opposite strand 297/320
(92 %)
5 diff
(98.5 %id)
AA295410 Pancreas .b 611 to 883 1 to 273       273/273
(100 %)
5 diff
(98.2 %id)
BI052802 placenta_normal .b 641 to 887 1 to 251       251/251
(100 %)
11 diff
(95.7 %id)
T80257 whole brain .b 642 to 1015 1 to 373       373/378
(98 %)
12 diff
(96.9 %id)
BF691299 melanotic melanoma, high MDR, skin .b 644 to 1184 1 to 536       536/893
(60 %)
22 diff
(97.6 %id)
BG015123 placenta_normal .b 658 to 895 21 to 260       240/260
(92 %)
7 diff
(97.4 %id)
BI052812 placenta_normal .b 660 to 758 100 to 2       99/100
(99 %)
0 diff
(100 %id)
BI055487 placenta_normal .b 660 to 914 253 to 4       250/253
(98 %)
0 diff
(100 %id)
BI055488 placenta_normal .b 660 to 909 256 to 10       247/256
(96 %)
0 diff
(100 %id)
BF311548 brain, neuroblastoma .b 736 to 1456 1 to 715       715/879
(81 %)
16 diff
(98.2 %id)
BE747801 adenocarcinoma cell line, ovary .b 757 to 1543 53 to 848       796/894
(89 %)
39 diff
(95.7 %id)
BF933089 nervous_tumor .b 779 to 895 117 to 1     Submitted on the opposite strand 117/121
(96 %)
1 diff
(99.2 %id)
BE736118 adenocarcinoma, Pancreas .b 797 to 1627 1 to 822       822/917
(89 %)
37 diff
(96.0 %id)
BQ308249 breast .b 805 to 1049 1 to 240       240/247
(97 %)
14 diff
(94.4 %id)
BQ308248 breast .b 806 to 1049 1 to 237       237/244
(97 %)
17 diff
(93.1 %id)
AL571302 placenta, Placenta Cot 25-normalized .b 807 to 1954 1140 to 1       1140/1185
(96 %)
12 diff
(99.0 %id)
BX410307 adult brain, brain .b 807 to 1637 1 to 834       834/834
(100 %)
27 diff
(96.8 %id)
BX410308 adult brain, brain .b 815 to 1651 1 to 836       836/861
(97 %)
22 diff
(97.5 %id)
AL522380 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 817 to 1750 1 to 935       935/935
(100 %)
3 diff
(99.7 %id)
BX365840 Neuroblastoma Cot 10-normalized .b 817 to 1518 1 to 703       703/703
(100 %)
5 diff
(99.3 %id)
CN306161 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 832 to 1587 1 to 758       758/758
(100 %)
7 diff
(99.1 %id)
BE742281 adenocarcinoma cell line, ovary .b 832 to 1218 1 to 388       388/924
(41 %)
13 diff
(98.6 %id)
BQ068555 brain, neuroblastoma, cell line .b 850 to 1649 1 to 806       806/1032
(78 %)
25 diff
(97.6 %id)
BM690917 eye, RPE and Choroid .b 864 to 1457 9 to 603       595/603
(98 %)
6 diff
(99.1 %id)
BQ923326 epidermoid carcinoma, cell line, lung .b 884 to 1636 1 to 754       754/917
(82 %)
6 diff
(99.4 %id)
BG695906 skin .b 888 to 1557 1 to 672       672/672
(100 %)
19 diff
(97.2 %id)
BQ674752 epidermoid carcinoma, cell line, salivary gland .b 927 to 1593 27 to 700       674/990
(68 %)
30 diff
(97.0 %id)
BQ670229 epidermoid carcinoma, cell line, salivary gland .b 928 to 1688 1 to 769       769/924
(83 %)
25 diff
(97.3 %id)
EC481725 Prostate .b 930 to 1017 89 to 2       88/89
(98 %)
0 diff
(100 %id)
CD672308 eye, Iris .b 945 to 1491 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
AL565130 adult brain, brain .b 948 to 1939 1001 to 12       990/1030
(96 %)
0 diff
(100 %id)
AL524074 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 949 to 1939 983 to 1   fully sequenced,   983/983
(100 %)
22 diff
(97.8 %id)
AL562745 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 987 to 1957 970 to 1       970/1095
(88 %)
14 diff
(98.8 %id)
BM987694 mixed .b 1031 to 1307 288 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 277/277
(100 %)
4 diff
(98.6 %id)
ES315301 occipital scalp hair, skin .b 1037 to 1180 1 to 144       144/144
(100 %)
0 diff
(100 %id)
BF899752 marrow .b 1058 to 1251 1 to 194       194/194
(100 %)
1 diff
(99.5 %id)
BE304978 adenocarcinoma cell line, colon .b 1083 to 1918 842 to 8       835/916
(91 %)
0 diff
(100 %id)
BE272285 adenocarcinoma cell line, ovary .b 1084 to 1728 1 to 645       645/648
(99 %)
7 diff
(99.0 %id)
AL581077 T cells from T cell leukemia .b 1088 to 1961 877 to 1   tiling clone,   877/877
(100 %)
4 diff
(99.6 %id)
AV683641 hepatocellular carcinoma .b 1120 to 1779 1 to 657       657/663
(99 %)
20 diff
(97.0 %id)
AV686000 hepatocellular carcinoma .b 1120 to 1533 1 to 408       408/408
(100 %)
8 diff
(98.1 %id)
AV688001 hepatocellular carcinoma .b 1120 to 1664 1 to 547       547/684
(79 %)
27 diff
(96.1 %id)
AV688003 hepatocellular carcinoma .b 1120 to 1646 1 to 523       523/612
(85 %)
6 diff
(99.1 %id)
AV688031 hepatocellular carcinoma .b 1120 to 1786 1 to 665       665/672
(98 %)
12 diff
(98.3 %id)
BM790600 stomach .b 1138 to 1730 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
BM312472 Pancreas, Purified pancreatic islet .b 1140 to 1639 1 to 500       500/500
(100 %)
4 diff
(99.2 %id)
BX401682   .b 1146 to 1944 827 to 15       813/924
(87 %)
0 diff
(100 %id)
CA777753 Pancreas, Purified pancreatic islet .b 1152 to 1298 1 to 147       147/147
(100 %)
1 diff
(99.4 %id)
AW880383 ovary .b 1165 to 1325 161 to 1       161/161
(100 %)
1 diff
(99.4 %id)
BI518267 pooled colon, kidney, stomach .b 1183 to 1942 762 to 1       762/763
(99 %)
12 diff
(98.5 %id)
TI_45236337   .b 1183 to 1942 762 to 1       762/763
(99 %)
12 diff
(98.5 %id)
BF675427 Prostate .b 1185 to 1913 3 to 721       719/861
(83 %)
41 diff
(95.3 %id)
BM510395 insulinoma, Pancreas .b 1238 to 1660 1 to 423       423/423
(100 %)
4 diff
(99.1 %id)
AV747266 Pituitary .b 1262 to 1654 1 to 398       398/400
(99 %)
23 diff
(94.3 %id)
BF899753 marrow .b 1267 to 1550 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
CB105417 Liver .b 1284 to 1836 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
BF873415 lung_tumor .b 1285 to 1643 359 to 1     Submitted on the opposite strand 359/359
(100 %)
2 diff
(99.5 %id)
BF943614 nervous_normal .b 1292 to 1753 480 to 16     Submitted on the opposite strand 465/496
(93 %)
0 diff
(100 %id)
BI048663 testis_normal .b 1294 to 1696 416 to 12       405/418
(96 %)
0 diff
(100 %id)
R71837 breast .b 1336 to 1712 1 to 377       377/377
(100 %)
6 diff
(98.5 %id)
CN306162 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1342 to 1614 1 to 273       273/273
(100 %)
0 diff
(100 %id)
BE828048 lung_tumor .b 1396 to 1669 1 to 274       274/380
(72 %)
2 diff
(99.5 %id)
CF141784 CNCAP(3)T-225 cell line, Prostate .b 1439 to 1663 1 to 224       224/224
(100 %)
6 diff
(97.4 %id)
BE089557 breast .b 1443 to 1661 169 to 387       219/387
(56 %)
6 diff
(98.5 %id)
FN060114 breast carcinoma .b 1458 to 1546 89 to 1     Submitted on the opposite strand 89/89
(100 %)
1 diff
(98.9 %id)
BE045280 normal epithelium, thyroid .b 1463 to 1666 19 to 222     Submitted on the opposite strand 204/222
(91 %)
6 diff
(97.3 %id)
AA248701   .b 1501 to 1731 1 to 237       237/237
(100 %)
14 diff
(94.1 %id)
F27065 pectoral muscle (after mastectomy) .b 1522 to 1697 1 to 176       176/176
(100 %)
4 diff
(97.8 %id)
FN116421 breast carcinoma .b 1675 to 1752 76 to 1     Submitted on the opposite strand 76/83
(91 %)
3 diff
(96.4 %id)
FN055483 breast carcinoma .b 1679 to 1757 1 to 80       80/80
(100 %)
6 diff
(92.5 %id)
BG498704 adenocarcinoma, Prostate .b 1752 to 1903 1 to 151       151/151
(100 %)
3 diff
(98.1 %id)
BE742361 adenocarcinoma cell line, ovary .b 1835 to 1895 764 to 820       767/984
(77 %)
29 diff
(97.1 %id)
DB443092 testis .c 1 to 448 1 to 448   tiling clone,   448/450
(99 %)
14 diff
(96.9 %id)
CX166359 human embryonic stem cells differentiated toan early endodermal cell type .c 6 to 839 1 to 833   tiling clone,   833/833
(100 %)
4 diff
(99.6 %id)
CX166442 human embryonic stem cells differentiated toan early endodermal cell type .c 7 to 838 1 to 832       832/832
(100 %)
6 diff
(99.3 %id)
AF151815   .c 99 to 2075 1 to 1976 R38G I262T L292P L383P tiling clone,   1976/1976
(100 %)
9 diff
(99.6 %id)
W74177 Pancreas, pancreatic islet .c 325 to 728 1 to 410       408/410
(99 %)
8 diff
(98.1 %id)
AL561513 B cells from Burkitt lymphoma .d 1 to 691 1 to 675   tiling clone,   675/879
(76 %)
16 diff
(98.2 %id)
BX394514 Neuroblastoma Cot 25-normalized .d 5 to 752 1 to 749       749/829
(90 %)
39 diff
(95.3 %id)
DB477110 hippocampus .d 24 to 526 1 to 503       503/503
(100 %)
4 diff
(99.3 %id)
NM_015680.4   .d 24 to 2096 1 to 2073 L383P RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2073/2073
(100 %)
1 diff
(100.0 %id)
BM906673 ovary (pool of 3) .d 28 to 1042 1 to 1018       1018/1059
(96 %)
46 diff
(95.7 %id)
DB473778 hippocampus .d 29 to 491 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
BM924754 pooled colon, kidney, stomach .d 31 to 1038 20 to 1044       1025/1131
(90 %)
32 diff
(97.2 %id)
TI_57199304   .d 37 to 706 70 to 740       671/740
(90 %)
10 diff
(98.7 %id)
AY007160   .d 38 to 2096 1 to 2059 L383P tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2059/2059
(100 %)
1 diff
(100.0 %id)
BI821613 pooled brain, lung, testis .d 38 to 706 1 to 670       670/670
(100 %)
6 diff
(99.2 %id)
BC012821 Kidney, renal cell adenocarcinoma .d 39 to 2096 1 to 2058 I262T L292P L383P available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2058/2058
(100 %)
5 diff
(99.8 %id)
CA454612   .d 39 to 856 1 to 825       825/909
(90 %)
28 diff
(97.0 %id)
AW732451 Kidney, renal cell adenocarcinoma .d 40 to 469 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
BQ650711 hepatocellular carcinoma, cell line, Liver .d 41 to 646 1 to 605       605/956
(63 %)
18 diff
(98.2 %id)
CR746858 melanotic melanoma, skin .d 44 to 553 5 to 514       510/514
(99 %)
6 diff
(98.9 %id)
DB478642 hippocampus .d 46 to 513 1 to 468       468/468
(100 %)
3 diff
(99.4 %id)
BG716036 brain, hypothalamus .d 47 to 752 1 to 706       706/739
(95 %)
14 diff
(98.2 %id)
CR993333 T-Lymphocytes .d 49 to 656 1 to 608       608/613
(99 %)
2 diff
(99.7 %id)
BX426270 B cells (Ramos cell line) .d 50 to 934 1 to 875       875/892
(98 %)
50 diff
(94.4 %id)
CA393759 eye, RPE/choroid .d 50 to 530 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
TI_59394446   .d 51 to 803 88 to 841       754/754
(100 %)
6 diff
(99.3 %id)
DB494900 hypothalamus .d 52 to 542 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
DB499778 hypothalamus .d 52 to 547 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
BQ423826 melanotic melanoma, skin .d 52 to 856 1 to 816       816/925
(88 %)
24 diff
(97.5 %id)
BM016065 breast, mammary adenocarcinoma, cell line .d 53 to 803 1 to 752       752/752
(100 %)
6 diff
(99.3 %id)
CN306163 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 54 to 599 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BX441644 brain, fetal brain .d 54 to 1033 1 to 976       974/1010
(96 %)
13 diff
(98.8 %id)
AK075274 thyroid gland .d 55 to 2096 1 to 2042 S311R L383P available from FLJ,   2042/2042
(100 %)
4 diff
(99.9 %id)
BM822882 stomach .d 56 to 406 1 to 352       352/352
(100 %)
1 diff
(99.8 %id)
DB166477 thyroid gland .d 56 to 723 2 to 669   capped   668/668
(100 %)
2 diff
(99.8 %id)
DB477151 hippocampus .d 58 to 556 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BI758417 brain .d 58 to 752 23 to 731       707/858
(82 %)
20 diff
(97.7 %id)
TI_57218478   .d 58 to 752 23 to 731       707/858
(82 %)
20 diff
(97.7 %id)
BI769952 pooled lung and spleen .d 61 to 789 1 to 731       731/731
(100 %)
4 diff
(99.5 %id)
TI_57183376   .d 64 to 789 38 to 765       728/765
(95 %)
6 diff
(99.3 %id)
DR158864 human embryonic stem cells differentiated toan early endodermal cell type .d 65 to 754 1 to 691       691/691
(100 %)
2 diff
(99.8 %id)
AL550249 placenta, Placenta Cot 25-normalized .d 66 to 1058 1 to 994       992/994
(99 %)
9 diff
(99.1 %id)
CB996563 placenta, pre-eclamptic placenta .d 67 to 810 24 to 772       749/811
(92 %)
14 diff
(98.3 %id)
CB991347 placenta, pre-eclamptic placenta .d 67 to 686 24 to 646       623/822
(75 %)
18 diff
(97.9 %id)
CB992190 placenta, pre-eclamptic placenta .d 67 to 687 24 to 652       629/820
(76 %)
30 diff
(96.4 %id)
AK314975 cervix, tumor tissue .d 68 to 1408 1 to 1341 I262T L292P L383P     1341/1341
(100 %)
5 diff
(99.7 %id)
DB487405 hypothalamus .d 69 to 503 1 to 435       435/435
(100 %)
4 diff
(99.1 %id)
DB006565 cervix, tumor tissue .d 69 to 621 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BE410910 choriocarcinoma, placenta .d 71 to 664 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
BE409797 choriocarcinoma, placenta .d 72 to 747 45 to 729       683/777
(87 %)
34 diff
(95.7 %id)
BI906016 leukocyte .d 72 to 686 1 to 623       623/821
(75 %)
16 diff
(98.1 %id)
TI_57151323   .d 72 to 835 28 to 793       766/794
(96 %)
14 diff
(98.3 %id)
TI_57231428   .d 72 to 686 34 to 656       623/854
(72 %)
20 diff
(97.7 %id)
BG547085 lung .d 73 to 718 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BE910081 epithelioid carcinoma, Pancreas .d 75 to 728 1 to 655       655/656
(99 %)
8 diff
(98.8 %id)
TI_57214802   .d 76 to 935 24 to 904       879/935
(94 %)
33 diff
(96.5 %id)
BX325141   .d 78 to 795 1 to 718       718/718
(100 %)
16 diff
(97.8 %id)
BI762266 pooled colon, kidney, stomach .d 78 to 835 1 to 761       761/762
(99 %)
9 diff
(98.9 %id)
BP331581 rectum .d 79 to 663 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
CR616024 Placenta Cot 25-normalized .d 80 to 2067 1 to 1988 exact tiling clone,   1988/1988
(100 %)
0 diff
(100 %id)
AL548415 placenta, Placenta Cot 25-normalized .d 80 to 1042 1 to 962   fully sequenced,   962/962
(100 %)
11 diff
(98.9 %id)
BI752663 brain .d 81 to 935 1 to 876       874/907
(96 %)
28 diff
(97.0 %id)
BM050431 eye, normal pigmented retinal epithelium .d 83 to 682 1 to 602       602/639
(94 %)
9 diff
(98.6 %id)
BM544122 ovary (pool of 3) .d 84 to 1051 17 to 996       980/1064
(92 %)
29 diff
(97.3 %id)
BG982937 colon_normal .d 85 to 409 17 to 335       319/340
(93 %)
10 diff
(97.1 %id)
BQ055202 lymph, lymphoma, cell line .d 85 to 864 46 to 830       785/1134
(69 %)
30 diff
(97.4 %id)
BG470254 adenocarcinoma cell line, colon .d 87 to 846 1 to 771       771/774
(99 %)
19 diff
(97.6 %id)
BU172916 melanotic melanoma, skin .d 87 to 864 1 to 785       785/851
(92 %)
12 diff
(98.6 %id)
BC001393 Colon, adenocarcinoma .d 88 to 2096 1 to 2009 I262T L292P L383P available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2009/2009
(100 %)
6 diff
(99.8 %id)
BG576597 breast, mammary adenocarcinoma, cell line .d 88 to 723 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
BG576388 breast, mammary adenocarcinoma, cell line .d 89 to 933 1 to 852       852/858
(99 %)
23 diff
(97.4 %id)
BM905662 leiomyosarcoma, uterus .d 90 to 940 1 to 855       853/1047
(81 %)
17 diff
(98.4 %id)
TI_57149888   .d 90 to 865 35 to 818       784/920
(85 %)
22 diff
(97.7 %id)
TI_57152662   .d 90 to 847 68 to 823       756/823
(91 %)
8 diff
(99.1 %id)
BI764947 pooled colon, kidney, stomach .d 91 to 865 1 to 783       783/885
(88 %)
17 diff
(98.1 %id)
BI764556 pooled colon, kidney, stomach .d 91 to 847 1 to 755       755/755
(100 %)
3 diff
(99.7 %id)
BU509690 leiomyosarcoma, uterus .d 93 to 746 1 to 656       655/913
(71 %)
15 diff
(98.4 %id)
AW246989 lung, small cell carcinoma .d 96 to 559 1 to 464     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 464/464
(100 %)
6 diff
(98.8 %id)
BG685120 B-cells, primary B-cells from tonsils (cell line) .d 97 to 733 1 to 640       640/678
(94 %)
6 diff
(99.2 %id)
BG758016 B-cells, primary B-cells from tonsils (cell line) .d 97 to 743 1 to 652       652/762
(85 %)
21 diff
(97.3 %id)
CN306160 embryonic stem cells, DMSO-treated H9 cellline .d 98 to 552 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
CN306165 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 98 to 731 10 to 643       634/643
(98 %)
6 diff
(99.1 %id)
BI762711 pooled colon, kidney, stomach .d 98 to 1005 1 to 907       907/1011
(89 %)
22 diff
(97.9 %id)
TI_57150759   .d 98 to 1005 35 to 941       907/1045
(86 %)
28 diff
(97.4 %id)
BE208278 cervical carcinoma cell line, cervix .d 99 to 556 1 to 458     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 458/469
(97 %)
2 diff
(99.6 %id)
BY797135 eye .d 100 to 702 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
BI765940 pooled colon, kidney, stomach .d 100 to 797 25 to 724       701/725
(96 %)
13 diff
(98.3 %id)
TI_57149727   .d 100 to 797 25 to 724       701/725
(96 %)
13 diff
(98.3 %id)
BG765498 melanotic melanoma, high MDR (cell line), skin .d 101 to 933 1 to 842       839/936
(89 %)
30 diff
(96.8 %id)
BE249875 adenocarcinoma cell line, colon .d 107 to 865 1 to 754       754/815
(92 %)
9 diff
(98.9 %id)
BE293566 adenocarcinoma cell line, colon .d 107 to 695 1 to 589       589/592
(99 %)
9 diff
(98.5 %id)
BE293341 adenocarcinoma cell line, colon .d 107 to 747 1 to 636       636/656
(96 %)
12 diff
(98.2 %id)
BG424896 Kidney, renal cell adenocarcinoma .d 109 to 823 1 to 715       715/902
(79 %)
35 diff
(96.2 %id)
CR991764 T-Lymphocytes .d 110 to 849 1 to 739       739/741
(99 %)
3 diff
(99.6 %id)
DN997533 breast cancer, Mammary gland (cancer tissue) .d 116 to 814 1 to 699       699/699
(100 %)
8 diff
(98.9 %id)
BG746466 adenocarcinoma cell line, colon .d 122 to 674 1 to 553       553/554
(99 %)
3 diff
(99.5 %id)
BG248623 adenocarcinoma cell line, colon .d 123 to 858 1 to 725       725/760
(95 %)
27 diff
(96.5 %id)
BF317319 brain, neuroblastoma .d 126 to 752 1 to 619       619/871
(71 %)
14 diff
(98.4 %id)
TI_57176494   .d 139 to 818 81 to 753       673/780
(86 %)
11 diff
(98.6 %id)
CN306164 embryonic stem cells, DMSO-treated H9 cellline .d 140 to 727 1 to 589       589/589
(100 %)
7 diff
(98.9 %id)
BI829910 brain, medulla .d 140 to 818 1 to 672       672/699
(96 %)
9 diff
(98.8 %id)
CR615171 Placenta Cot 25-normalized .d 145 to 2061 1 to 1917 exact     1917/1917
(100 %)
0 diff
(100 %id)
BX282399 pooled colon, kidney, stomach .d 149 to 647 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
AL530042 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 151 to 964 1 to 812       812/812
(100 %)
2 diff
(99.8 %id)
W76116 heart .d 302 to 686 1 to 384       384/391
(98 %)
10 diff
(97.5 %id)
R61571 whole brain .d 462 to 903 1 to 452       452/454
(99 %)
18 diff
(96.1 %id)
AF070638 brain .d 749 to 2096 1 to 1348   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1348/1348
(100 %)
1 diff
(100.0 %id)
CR601240 Neuroblastoma Cot 10-normalized .d 924 to 2067 1 to 1144       1144/1144
(100 %)
0 diff
(100 %id)
AA293507 ovarian tumor, ovary .d 938 to 1454 1 to 515       515/515
(100 %)
8 diff
(98.5 %id)
AA430553 ovarian tumor, ovary .d 938 to 1138 1 to 199       199/199
(100 %)
5 diff
(97.5 %id)
AL572986 placenta, Placenta Cot 25-normalized .d 1012 to 2067 1052 to 1   fully sequenced,   1052/1052
(100 %)
11 diff
(99.0 %id)
AL574168 placenta, Placenta Cot 25-normalized .d 1067 to 2067 997 to 1       997/1001
(99 %)
11 diff
(99.0 %id)
AL522379 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .d 1084 to 2082 993 to 1       993/998
(99 %)
20 diff
(98.0 %id)
TI_227713168   .d 1113 to 2096 1063 to 92   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 972/1028
(94 %)
27 diff
(97.4 %id)
TI_227715748   .d 1128 to 2096 1046 to 91   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 956/1013
(94 %)
24 diff
(97.7 %id)
N32394 melanocyte .d 1168 to 1582 1 to 420       420/425
(98 %)
7 diff
(98.4 %id)
AL563628 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1189 to 2079 892 to 1       892/892
(100 %)
4 diff
(99.6 %id)
AL582796 B cells from Burkitt lymphoma .d 1209 to 2065 862 to 1       862/862
(100 %)
23 diff
(97.4 %id)
TI_227712811   .d 1215 to 2096 957 to 78   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 880/1038
(84 %)
16 diff
(98.5 %id)
N57362 placenta .d 1224 to 1452 1 to 229       229/233
(98 %)
5 diff
(97.9 %id)
BQ675766 epidermoid carcinoma, cell line, salivary gland .d 1237 to 2095 1 to 865       865/925
(93 %)
22 diff
(97.7 %id)
T51747 fetal spleen, Spleen .d 1253 to 1635 1 to 393       393/395
(99 %)
15 diff
(96.3 %id)
BX435784 B cells (Ramos cell line) .d 1265 to 2092 835 to 1       835/924
(90 %)
23 diff
(97.6 %id)
BX325140   .d 1293 to 2031 742 to 1       742/742
(100 %)
40 diff
(94.7 %id)
BX365839 Neuroblastoma Cot 10-normalized .d 1302 to 2067 766 to 1       766/766
(100 %)
16 diff
(98.0 %id)
AW081854 esophagus, squamous cell carcinoma .d 1343 to 2097 760 to 5       756/760
(99 %)
0 diff
(100 %id)
AA412624   .d 1350 to 1776 1 to 426   fully sequenced,   426/426
(100 %)
1 diff
(99.8 %id)
BE794984 lung, small cell carcinoma .d 1350 to 2093 1 to 734       734/844
(86 %)
14 diff
(98.4 %id)
W31832 parathyroid gland, parathyroid tumor .d 1365 to 1791 1 to 428       428/428
(100 %)
8 diff
(98.2 %id)
BU856658 adenocarcinoma, cell line, breast .d 1368 to 2096 1 to 729   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 729/729
(100 %)
1 diff
(99.9 %id)
BM908152 brain, medulla .d 1373 to 2097 1 to 725       725/728
(99 %)
1 diff
(99.9 %id)
TI_154038242   .d 1384 to 2096 764 to 58   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 707/776
(91 %)
21 diff
(97.3 %id)
BX435195 brain, fetal brain .d 1390 to 2082 709 to 1       709/765
(92 %)
66 diff
(91.4 %id)
AV699904 hepatocellular carcinoma .d 1391 to 2082 685 to 1       685/686
(99 %)
44 diff
(93.6 %id)
BQ009785 Chondrosarcoma, Left Pubic Bone .d 1404 to 2096 711 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 693/693
(100 %)
0 diff
(100 %id)
BE305172 adenocarcinoma cell line, colon .d 1405 to 2039 638 to 2       637/638
(99 %)
0 diff
(100 %id)
CD366858 Alveolar Macrophage, lung .d 1416 to 2096 699 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 681/681
(100 %)
1 diff
(99.9 %id)
BM925986 brain .d 1421 to 2092 11 to 690       680/1242
(54 %)
20 diff
(98.4 %id)
BE747415 adenocarcinoma cell line, ovary .d 1441 to 2096 1 to 655   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 655/655
(100 %)
2 diff
(99.7 %id)
CD742850 Alveolar Macrophage, lung .d 1445 to 2096 670 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 652/652
(100 %)
4 diff
(99.4 %id)
CA313272 Human Lung Epithelial cells, lung .d 1450 to 2096 665 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
BU616246 Bone, Subchondral Bone .d 1451 to 2096 665 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 647/647
(100 %)
2 diff
(99.7 %id)
CD367502 Alveolar Macrophage, lung .d 1451 to 2096 664 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 646/646
(100 %)
1 diff
(99.9 %id)
BU631754 cell lines, Chondrosarcoma .d 1457 to 2096 658 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 640/640
(100 %)
1 diff
(99.9 %id)
CA421693 Bone, Enchondroma cell line .d 1457 to 2096 657 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 639/639
(100 %)
2 diff
(99.7 %id)
BM042013 melanotic melanoma, cell line, skin .d 1482 to 2097 1 to 616   fully sequenced,   616/616
(100 %)
1 diff
(99.9 %id)
BM042659 melanotic melanoma, cell line, skin .d 1483 to 2024 544 to 2   fully sequenced,   543/544
(99 %)
0 diff
(100 %id)
BU166678 melanotic melanoma, cell line, skin .d 1483 to 2096 32 to 645   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 614/645
(95 %)
6 diff
(99.1 %id)
BE737850 brain, glioblastoma .d 1490 to 2030 1 to 534       534/704
(75 %)
10 diff
(98.6 %id)
BX331147   .d 1491 to 2075 585 to 1       585/845
(69 %)
32 diff
(96.3 %id)
BM508209 insulinoma, Pancreas .d 1529 to 2096 583 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 568/568
(100 %)
0 diff
(100 %id)
CK823699 insulinoma, Pancreas .d 1533 to 2067 535 to 1       535/535
(100 %)
7 diff
(98.7 %id)
DB382530 thyroid gland .d 1536 to 2096 560 to 1       560/560
(100 %)
16 diff
(97.2 %id)
TI_159697540   .d 1539 to 2096 705 to 150   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 556/867
(64 %)
28 diff
(96.8 %id)
BI910898 leukocyte .d 1548 to 2096 1 to 548   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 548/548
(100 %)
5 diff
(99.1 %id)
TI_57235682   .d 1548 to 2096 1 to 548   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 548/548
(100 %)
5 diff
(99.1 %id)
AI924623 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 1553 to 2097 547 to 3       545/547
(99 %)
0 diff
(100 %id)
TI_154172581   .d 1553 to 2077 80 to 604       525/603
(87 %)
50 diff
(91.8 %id)
BQ786999 Pancreas, Purified pancreatic islet .d 1562 to 2095 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
BF663852 B-cells, primary B-cells from tonsils (cell line) .d 1587 to 2060 1 to 472       472/701
(67 %)
4 diff
(99.5 %id)
BE208811 Kidney, renal cell adenocarcinoma .d 1590 to 2097 513 to 6       508/513
(99 %)
0 diff
(100 %id)
DB486840 hypothalamus .d 1596 to 2015 1 to 419       419/421
(99 %)
16 diff
(96.2 %id)
BP396600 pancreatic islet .d 1602 to 2095 1 to 494     Submitted on the opposite strand 494/497
(99 %)
2 diff
(99.6 %id)
CA444615 lung, Metastatic Chondrosarcoma .d 1604 to 2096 511 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 493/502
(98 %)
1 diff
(99.9 %id)
TI_151737208   .d 1608 to 2096 582 to 94   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 489/489
(100 %)
2 diff
(99.6 %id)
AI745446 ovary, tumor, 5 pooled (see description) .d 1609 to 2097 496 to 8       489/496
(98 %)
0 diff
(100 %id)
AI139305 uterus .d 1620 to 2096 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI978809 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1620 to 2096 488 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 477/477
(100 %)
0 diff
(100 %id)
BG056186 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .d 1620 to 2097 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AI978820 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1621 to 2096 487 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 476/476
(100 %)
0 diff
(100 %id)
BP420283 small intestine .d 1625 to 2096 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
DB565945 hypothalamus .d 1626 to 2096 1 to 471     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
W17252 lung .d 1626 to 2091 1 to 459   fully sequenced,   459/459
(100 %)
10 diff
(97.9 %id)
AI972073 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1628 to 2096 496 to 28   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 469/469
(100 %)
1 diff
(99.8 %id)
AJ708672 heart .d 1629 to 2097 469 to 1     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
AI719131 aorta .d 1631 to 2096 466 to 1       466/466
(100 %)
3 diff
(99.4 %id)
DB570916 hypothalamus .d 1634 to 2096 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
R61515 whole brain .d 1636 to 2097 476 to 9       468/477
(98 %)
0 diff
(100 %id)
DB542547 hippocampus .d 1638 to 2096 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
DB545804 hippocampus .d 1644 to 2094 1 to 451     Submitted on the opposite strand 451/453
(99 %)
2 diff
(99.6 %id)
BP395053 pancreatic islet .d 1644 to 2059 1 to 418     Submitted on the opposite strand 418/418
(100 %)
4 diff
(99.1 %id)
AW262942 adenocarcinoma, Pancreas .d 1645 to 2096 463 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
AW009572 colon .d 1647 to 2097 454 to 4       451/454
(99 %)
0 diff
(100 %id)
DB558992 hypothalamus .d 1649 to 2096 1 to 448     Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
W72304 heart .d 1650 to 2097 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
AA938156 germinal center B cell .d 1650 to 2096 483 to 37   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 447/447
(100 %)
1 diff
(99.8 %id)
DB545772 hippocampus .d 1654 to 2096 1 to 443     Submitted on the opposite strand 443/443
(100 %)
0 diff
(100 %id)
AI246124 follicular lymphoma, lymph node .d 1658 to 2097 441 to 2       440/441
(99 %)
0 diff
(100 %id)
DB547306 hippocampus .d 1665 to 2096 1 to 432     Submitted on the opposite strand 432/432
(100 %)
0 diff
(100 %id)
DB556754 hypothalamus .d 1667 to 2096 1 to 430     Submitted on the opposite strand 430/430
(100 %)
0 diff
(100 %id)
DB509292 testis .d 1675 to 2096 1 to 424     Submitted on the opposite strand 424/424
(100 %)
4 diff
(99.1 %id)
N22978 melanocyte .d 1675 to 2096 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
AA826601 carcinoid, lung .d 1675 to 2096 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AI189642 placenta .d 1675 to 2097 431 to 9       423/431
(98 %)
0 diff
(100 %id)
AI150544   .d 1675 to 2097 427 to 5       423/427
(99 %)
0 diff
(100 %id)
AA908727 carcinoid, lung .d 1676 to 2096 421 to 1       421/421
(100 %)
5 diff
(98.9 %id)
DB514736 testis .d 1678 to 2096 1 to 419     Submitted on the opposite strand 419/419
(100 %)
1 diff
(99.8 %id)
AW088575 ovary, tumor, 5 pooled (see description) .d 1678 to 2096 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
DB508017 testis .d 1679 to 2096 1 to 417     Submitted on the opposite strand 417/417
(100 %)
11 diff
(97.4 %id)
AI033987 parathyroid gland, parathyroid tumor .d 1685 to 2097 420 to 8       413/420
(98 %)
0 diff
(100 %id)
AW129123 brain, tumor, 5 pooled (see description) .d 1685 to 2096 428 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
AI147719 brain, glioblastoma (pooled) .d 1687 to 2096 427 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
EL950470 eyeball .d 1688 to 2096 30 to 439   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 410/439
(93 %)
6 diff
(98.7 %id)
BE301384 cervical carcinoma cell line, cervix .d 1689 to 2096 425 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
AA181715   .d 1691 to 2096 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
AI167851 parathyroid gland, parathyroid tumor .d 1692 to 2096 417 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
AW471363 adenocarcinoma, Pancreas .d 1692 to 2096 417 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
AI246553 pharynx, squamous cell carcinoma .d 1693 to 2097 412 to 8       405/412
(98 %)
0 diff
(100 %id)
DB512871 testis .d 1698 to 2096 1 to 397     Submitted on the opposite strand 397/397
(100 %)
16 diff
(96.0 %id)
W31993 parathyroid gland, parathyroid tumor .d 1700 to 1941 1 to 250   fully sequenced,   250/250
(100 %)
0 diff
(100 %id)
T03716   .d 1703 to 2096 396 to 1       396/400
(99 %)
4 diff
(99.0 %id)
AW300743 colon, moderately differentiated adenocarcinoma .d 1703 to 2096 418 to 25   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 394/394
(100 %)
5 diff
(98.8 %id)
BP394447 pancreatic islet .d 1710 to 2093 1 to 381     Submitted on the opposite strand 381/382
(99 %)
7 diff
(98.2 %id)
AI869730 anaplastic oligodendroglioma, brain .d 1712 to 2095 387 to 4       384/387
(99 %)
0 diff
(100 %id)
BM715339 eye, human retina .d 1713 to 2097 1 to 385       385/421
(91 %)
1 diff
(99.8 %id)
BM718331 eye, fetal eye .d 1713 to 2096 1 to 384   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 384/384
(100 %)
0 diff
(100 %id)
BF673453 Prostate .d 1715 to 2010 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
AI370457   .d 1716 to 2096 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AA996212 carcinoid, lung .d 1720 to 2027 1 to 308     Submitted on the opposite strand 308/308
(100 %)
4 diff
(98.8 %id)
AJ709855 heart .d 1721 to 2096 20 to 394   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 375/394
(95 %)
13 diff
(96.8 %id)
AI672716 thymus, pooled .d 1722 to 2096 386 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
T51593 fetal spleen, Spleen .d 1725 to 2097 376 to 2       375/463
(80 %)
0 diff
(100 %id)
AA587091 colon, colon tumor RER+ .d 1736 to 2096 361 to 1       361/361
(100 %)
2 diff
(99.5 %id)
AA706419   .d 1744 to 2095 353 to 1     Submitted on the opposite strand 353/353
(100 %)
1 diff
(99.8 %id)
AA412483   .d 1746 to 2102 360 to 4   fully sequenced,   357/360
(99 %)
5 diff
(98.7 %id)
AA430554 ovarian tumor, ovary .d 1765 to 2097 338 to 6       333/338
(98 %)
0 diff
(100 %id)
AA401768 ovarian tumor, ovary .d 1767 to 2097 336 to 6       331/336
(98 %)
0 diff
(100 %id)
AI886067 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1767 to 2096 343 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 330/330
(100 %)
0 diff
(100 %id)
BX353087 Neuroblastoma Cot 10-normalized .d 1768 to 2097 1 to 330       330/330
(100 %)
1 diff
(99.7 %id)
AI434185 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1770 to 2096 357 to 31   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 327/327
(100 %)
0 diff
(100 %id)
BF448745 sympathetic trunk .d 1772 to 2097 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AW338391 adenocarcinoma, Pancreas .d 1774 to 2097 324 to 1       324/324
(100 %)
0 diff
(100 %id)
AA722851 heart .d 1776 to 2097 325 to 4       322/325
(99 %)
0 diff
(100 %id)
AI310688 2 pooled tumors (clear cell type), Kidney .d 1786 to 2096 333 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 311/311
(100 %)
9 diff
(97.2 %id)
AI310690 2 pooled tumors (clear cell type), Kidney .d 1786 to 2096 333 to 21       313/333
(93 %)
0 diff
(100 %id)
AI499595 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1791 to 2096 321 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 306/306
(100 %)
0 diff
(100 %id)
W04584 parathyroid gland, parathyroid tumor .d 1792 to 2096 305 to 1       305/307
(99 %)
3 diff
(99.1 %id)
DB556132 hypothalamus .d 1818 to 2096 1 to 282     Submitted on the opposite strand 282/282
(100 %)
9 diff
(96.9 %id)
AI421141 brain, glioblastoma (pooled) .d 1820 to 2096 272 to 1       272/272
(100 %)
9 diff
(96.7 %id)
AI708829 aorta .d 1820 to 2096 280 to 4       277/280
(98 %)
0 diff
(100 %id)
AA503525 colon .d 1824 to 2095 271 to 1       271/271
(100 %)
1 diff
(99.7 %id)
AW131170 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1851 to 2097 254 to 8       247/254
(97 %)
0 diff
(100 %id)
BQ213859 embryonal carcinoma, cell line, testis .d 1855 to 2096 1 to 242   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 242/242
(100 %)
0 diff
(100 %id)
AI183822   .d 1867 to 2097 239 to 9       231/239
(96 %)
0 diff
(100 %id)
N29429 placenta .d 1870 to 2096 227 to 1       227/234
(97 %)
7 diff
(97.1 %id)
AW104591 pooled .d 1882 to 2097 218 to 3       216/218
(99 %)
0 diff
(100 %id)
AI337487 lung .d 1887 to 2094 208 to 1       208/211
(98 %)
4 diff
(98.2 %id)
BF034466 adenocarcinoma, ovary .d 1894 to 2092 199 to 1     Submitted on the opposite strand 199/288
(69 %)
0 diff
(100 %id)
W31433 parathyroid gland, parathyroid tumor .d 1911 to 2096 187 to 1   fully sequenced,   187/187
(100 %)
3 diff
(98.4 %id)
CF131294 Chondrosarcoma Lung Metastasis cell lines, lung .d 1912 to 2096 1 to 185   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 185/185
(100 %)
0 diff
(100 %id)
D20408   .d 1933 to 2097 1 to 165     Submitted on the opposite strand 165/167
(98 %)
1 diff
(99.5 %id)
AW250191 lung, small cell carcinoma .d 1951 to 2096 156 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 146/146
(100 %)
6 diff
(95.9 %id)
N78853 lung .d 1974 to 2097 124 to 1   fully sequenced,   124/124
(100 %)
1 diff
(99.2 %id)
CR981902 T-Lymphocytes .e 1 to 858 1 to 858   tiling clone,   858/858
(100 %)
1 diff
(99.9 %id)
DA956071 Spleen .e 39 to 585 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BM769102 stomach .e 368 to 919 1 to 552   tiling clone,   552/552
(100 %)
0 diff
(100 %id)
BF800373 colon_ins .e 429 to 685 15 to 271       257/271
(94 %)
6 diff
(97.8 %id)
BG424773 Kidney, renal cell adenocarcinoma .f 1 to 743 1 to 740 E186A E187G E188G V189G F190L ... tiling clone,   740/743
(99 %)
13 diff
(98.3 %id)
TI_45209068   .f 15 to 829 80 to 892       813/974
(83 %)
19 diff
(98.1 %id)
BI596640 brain, hypothalamus .f 20 to 829 1 to 809   tiling clone,   809/891
(90 %)
16 diff
(98.3 %id)
CB046403 2 pooled tumors (clear cell type), Kidney .g-u 1 to 499 528 to 30 T98N tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 499/503
(99 %)
4 diff
(99.3 %id)
BX112072 2 pooled tumors (clear cell type), Kidney .g-u 6 to 486 1 to 480 exact tiling clone,   480/480
(100 %)
3 diff
(99.4 %id)
AI302091 2 pooled tumors (clear cell type), Kidney .g-u 51 to 502 452 to 1   tiling clone,   452/452
(100 %)
1 diff
(99.8 %id)
CX787239 human embryonic stem cells .h-u 1 to 628 1 to 628 P38A tiling clone,   628/628
(100 %)
2 diff
(99.7 %id)
AI378566 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1 to 491 492 to 2 exact tiling clone,   491/492
(99 %)
0 diff
(100 %id)
CT000453 T-Lymphocytes Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
AV684764 hepatocellular carcinoma Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
BU685030 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene C2orf24, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AK311656 thymus Gene C2orf24, variant not shown         This clone was ignored    
BE720108 head_neck Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
AW978701   Gene C2orf24, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AW969495   Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
AA612621 Prostate, prostate tumor Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
AA824542 germinal center B cell Gene C2orf24, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI814202 normal prostate, Prostate Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
BG424942 Kidney, renal cell adenocarcinoma Gene C2orf24, variant not shown         This clone was ignored    
BG718382 testis Gene C2orf24, variant not shown         This clone was ignored    
BM924735 pooled colon, kidney, stomach Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
BU165036 eye, retinoblastoma Gene C2orf24, variant not shown         Suspected internal deletion, this clone was ignored    
DB138672 thymus Gene C2orf24, variant not shown       capped This clone was ignored    
DB345211 thymus Gene C2orf24, variant not shown         This clone was ignored    
TI_149299855   Gene C2orf24, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u, .i Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C